Share Issue/Capital Change • Oct 27, 2020
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE TO OR WITHIN THE UNITED STATES OF AMERICA, CANADA, SWITZERLAND, JAPAN, SOUTH AFRICA, AUSTRALIA OR ANY OTHER COUNTRY OR JURISDICTION WHERE ITS DISSEMINATION WOULD BE CONTRARY TO LAW OR OTHER RESTRICTIONS APPLY.

27 October 2020
Public limited liability company Public regulated real estate company under Belgian law Office: Rue Belliard 40 (box 11), 1040 Brussels Enterprise number: 0877.248.501 (RLE Brussels, French division) (the 'Company')
Following the public offering of New Shares within the framework of a capital increase in cash within the authorised capital with priority allocation rights as announced on 14 October 2020, 5,499,373 new shares were issued today. Consequently, the total number of Aedifica shares now amounts to 32,996,242.
The new shares were issued without coupon No. 26 attached, which grants right to the pro rata temporis dividend of the current financial year 2019/2020 (ending on 31 December 2020) for the period starting from 1 July 2020 (including) up to and including 26 October 2020. These new shares shall therefore only participate pro rata temporis in the results of the current financial year 2019/2020 as from 27 October 2020. Coupon No. 26 was detached on 14 October 2020 after closing of the markets. The existing shares and the new shares each have coupon No. 27 and following attached, and are thus fungible.
Each of these shares confers the right to one vote at the General Meeting of Shareholders and the total number of shares (i.e. 32,996,242) thus represents the new denominator for purposes of notifications within the framework of the transparency regulation. Following this transaction, the share capital of Aedifica amounts to EUR 870,697,700.20.
This information, as well as the shareholding structure, is available on the website of Aedifica NV/SA (aedifica.eu).
The 5,499,373 new Aedifica shares issued today are admitted to trading on the regulated markets of Euronext Brussels and Euronext Amsterdam and have the same ISIN-code as the existing Aedifica shares (BE0003851681).
NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE TO OR WITHIN THE UNITED STATES OF AMERICA, CANADA, SWITZERLAND, JAPAN, SOUTH AFRICA, AUSTRALIA OR ANY OTHER COUNTRY OR JURISDICTION WHERE ITS DISSEMINATION WOULD BE CONTRARY TO LAW OR OTHER RESTRICTIONS APPLY.

27 October 2020
Aedifica is a Regulated Real Estate Company under Belgian law specialised in European healthcare real estate, particularly in senior housing. Aedifica has developed a portfolio of more than 450 sites in Belgium, Germany, the Netherlands, the United Kingdom, Finland and Sweden, worth approximately €3.5 billion.
Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019) and is identified by the following ticker symbols: AED; AED:BB (Bloomberg); AOO.BR (Reuters).
Since March 2020, Aedifica is part of the BEL 20, the leading share index of Euronext Brussels. Aedifica's market capitalisation was approx. €2.9 billion as of 26 October 2020.
Aedifica is included in the EPRA and Stoxx Europe 600 indices.
Stefaan Gielens mrics Chief Executive Officer
Ingrid Daerden Chief Financial Officer
T +32 2 626 07 72 [email protected]
T +32 494 573 115 [email protected]
Bob Boeckx Copywriter financial communication
T +32 496 279 979 [email protected]
Discover Aedifica's Sustainability Report

NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE TO OR WITHIN THE UNITED STATES OF AMERICA, CANADA, SWITZERLAND, JAPAN, SOUTH AFRICA, AUSTRALIA OR ANY OTHER COUNTRY OR JURISDICTION WHERE ITS DISSEMINATION WOULD BE CONTRARY TO LAW OR OTHER RESTRICTIONS APPLY.

27 October 2020
These written materials are not for distribution in or to persons resident in the United States of America, Australia, Canada, Japan, South Africa or Switzerland. The information contained herein does not constitute an offer of securities for sale in the United States of America, Australia, Canada, Japan, South Africa or Switzerland.
The Company's securities referred to herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the Securities Act), or under the laws of any state or other jurisdiction in the United States of America, and may not be offered or sold within the United States of America except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state laws. No public offering of securities will be made in the United States of America.
This information does not constitute an offer or invitation to proceed to an acquisition of or subscription for the Company's securities, nor an offer or invitation to proceed to an acquisition of or subscription for the Company's securities in the United States of America, Switzerland, Canada, Australia, Japan, South Africa or in any other jurisdiction where such offer or invitation is not allowed without registration or qualification under the applicable legislation of the relevant jurisdiction, or where such offer or invitation does not meet the required conditions under the applicable legislation of the relevant jurisdiction.
This information and any materials distributed in connection with this information are not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident of or located in the United States of America, Switzerland, Canada, Australia, Japan, South Africa or any other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such jurisdiction. Any failure to comply with these restrictions may constitute a violation of the laws or regulations of the United States of America, Switzerland, Canada, Australia, Japan, South Africa or any other jurisdiction. The distribution of this information in other jurisdictions than Belgium, may be restricted by laws or regulations applicable in such jurisdictions. All persons in possession of this information must inform themselves about, and comply with, any such restrictions.
An investment in shares entails significant risks. Relevant investors are encouraged to read the Prospectus that is made available on the website of Aedifica NV/SA (aedifica.eu/investors/capital-increases).
This document is not a prospectus and investors should not subscribe for or purchase any shares referred to herein except on the basis of the information contained in the Prospectus. Potential investors must read the Prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with the decision to invest in the securities. The approval of the Prospectus should not be understood as an endorsement of the securities offered or admitted to trading on a regulated market.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.